Intraperitoneal interferon-α in residual ovarian carcinoma: A phase II gynecologic oncology group study

Jonathan S. Berek, Maurie Markman, Bette Stonebraker, Samuel S. Lentz, Mark D. Adelson, Koenraad De Geest, David Moore

Research output: Contribution to journalArticle

53 Scopus citations

Abstract

Objective. The purpose of this study was to confirm the activity of interferon-α intraperitoneally in minimal residual epithelial ovarian cancer in a Phase II multi-institutional trial and to investigate the activity of the agent based on prior response to first-line platinum compounds. Methods. Ninety-two patients with minimal residual (

Original languageEnglish (US)
Pages (from-to)10-14
Number of pages5
JournalGynecologic Oncology
Volume75
Issue number1
DOIs
Publication statusPublished - Oct 1999
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this